Publications Marianne van Stipdonk, head of the Centre for Immunology of Infectious Diseases and Vaccines at the Dutch National Institute for Public Health and the Environment (RIVM).

Ly,L.V., M.Sluijter, M.Versluis, G.P.Luyten, M.J.van Stipdonk, S.H.van der Burg, C.J.Melief, M.J.Jager, and T.van Hall. 2010. Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm. Cancer Res. 70:8339-8346.

Fransen,M.F., M.J.van Stipdonk, M.Sluijter, S.P.Schoenberger, C.J.Melief, and R.Offringa. 2010. Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation. J. Immunol. 185:3167-3173.

van Stipdonk, M.J., D. Badia-Martinez, M. Sluijter, R. Offringa, T. van Hall, and A. Achour. Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100. 2009. Cancer Res 69:7784-7792.

van Stipdonk, M.J., M. Sluijter, W.G. Han, and R. Offringa. Development of CTL memory despite arrested clonal expansion. 2008. Eur J Immunol. 38:1839-46.

Kel, J.M., E.D. de Geus, M.J. van Stipdonk, J.W. Drijfhout, F. Koning, and L. Nagelkerken. Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. 2008. Int Immunol 20:117-27.

Rahmouni, S., T. Vang, A. Alonso, S. Williams, M. van Stipdonk, C. Soncini, M. Moutschen, S.P. Schoenberger, and T. Mustelin. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein. 2005 Mol Cell Biol 25:2227-41.

van Stipdonk,M.J., G. Hardenberg, M.S. Bijker, E.E. Lemmens, N.M. Droin, D.R. Green, and S.P. Schoenberger. 2003. Dynamic programming of CD8(+) T lymphocyte responses. Nat Immunol 4:361-5.

Alonso,A., S. Rahmouni, S. Williams, M. van Stipdonk, L. Jaroszewski, A. Godzik, R.T. Abraham, S.P. Schoenberger, and T. Mustelin. 2003. Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nat Immunol 4:44-8.

Homann, D., A. Jahreis, T. Wolfe, A. Hughes, B. Coon, M.J. van Stipdonk, K.R. Prilliman, S.P. Schoenberger, and M.G. von Herrath. 2002. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16:403-15.

Bi, K., Y. Tanaka, N. Coudronniere, K. Sugie, S. Hong, M.J. van Stipdonk, and A. Altman. 2001. Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation. Nat Immunol 2:556-63.

Van Stipdonk, M.J., E.E. Lemmens, and S.P. Schoenberger. 2001. Naïve cytotoxic T lymphocytes require a single brief period of antigenic stimulation for expansion and differentiation. Nat Immunol 2:423-9.

Van Stipdonk, M.J., A.A. Willems, R. Verbeek, C.J. Boog, and J.M. van Noort. 2000. T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis. Cell Immunol 204:128-34.

Van Stipdonk, M.J., A.A. Willems, A.C. Plomp, J.M. van Noort, and C.J. Boog. 2000. Tolerance controls encephalitogenicity of alphaB-crystallin in the Lewis rat. J Neuroimmunol 103:103-11.

Van Noort, J.M., J.J. Bajramovic, A.C. Plomp, and M.J. van Stipdonk. 2000. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis. J Neuroimmunol 105:46-57.

Thoua, N.M., J.M. van Noort, D. Baker, A. Bose, A.C. van Sechel, M.J. van Stipdonk, P.J. Travers, and S. Amor. 2000. Encephalitogenic and immunogenic potential of the stress protein alphaB- crystallin in Biozzi ABH (H-2A(g7)) mice. J Neuroimmunol 104:47-57.

Van Sechel, A.C., J.J. Bajramovic, M.J. van Stipdonk, C. Persoon-Deen, S.B. Geutskens, and J.M. van Noort. 1999. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 162:129-35.

Van Stipdonk, M.J., A.A. Willems, S. Amor, C. Persoon-Deen, P.J. Travers, C.J. Boog, and J.M. van Noort. 1998. T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. Int Immunol 10:943-50.

Laman, J.D., C.B. Maassen, M.M. Schellekens, L. Visser, M. Kap, E. de Jong, M. van Puijenbroek, M.J. van Stipdonk, M. van Meurs, C. Schwarzler, and U. Gunthert. 1998. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Mult Scler 4:147-53.

Van Noort, J.M., A.C. van Sechel, M.J. van Stipdonk, and J.J. Bajramovic. 1998. The small heat shock protein alpha B-crystallin as key autoantigen in multiple sclerosis. Prog Brain Res 117:435-52.

Broeren, C.P., M.A. Lucassen, M.J. van Stipdonk, R. van der Zee, C.J. Boog, J.G. Kusters, and W. van Eden. 1994. CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. Proc Natl Acad Sci U S A 91:5997-6001.